Navigation Links
Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
Date:10/31/2007

COLUMBIA, Mo. Heart disease is the leading cause of death in the United States and greatly affects the quality and length of life for individuals with specific forms of muscular dystrophy. Recent discoveries have demonstrated that gene and/or stem cell therapy could help a variety of organs in the body, but until now scientists have been unsure whether the heart could benefit from these treatments. According to a new study, recently published in Circulation Research, a journal of the American Heart Association, University of Missouri-Columbia researchers have demonstrated that a muscular dystrophy patient should be able to maintain a normal lifestyle if only 50 percent of the cells of the heart are healthy.

Patients with Duchenne muscular dystrophy and Becker muscular dystrophy have a gene mutation that disrupts the production of a protein known as dystrophin. Absence of this protein starts a chain reaction that eventually leads to muscle cell degeneration and death. Eventually, the damaged muscle tissue is replaced by fibrous, bony or fatty tissue and loses function. In the heart, this leads to severe heart disease and can place severe limitations on individuals afflicted with the disease.

In the past, scientists believed that the only way to have a healthy heart was to rid the heart of all damaged tissue. The heart is considered to be a synchronized organ; therefore, it was believed that the heart needed to maintain 100 percent normal cells in order to stay healthy.

In gene therapy, mutated genes are replaced with healthy genes. In stem cell therapy, diseased cells are replaced with healthy cells. However, in these gene and stem cell therapies, it is not feasible to fix every cell in the heart. Previously, scientists were uncertain whether partial correction could benefit patients.

In our study, we found that a heart with 50 percent normal cells looks like a normal heart, said Dongsheng Duan, an associate professor of mo
'/>"/>

Contact: Christian Basi
BasiC@missouri.edu
573-882-4430
University of Missouri-Columbia
Source:Eurekalert

Page: 1 2

Related biology news :

1. Silence the gene, save the cell: RNA interference as promising therapy for ALS
2. Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers
3. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
4. Columbia research lifts major hurdle to gene therapy for cancer
5. Combination therapy boosts effectiveness of telomere-directed cancer cell death
6. Gene therapy converts dead bone graft to new, living tissue
7. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
8. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
11. Gene Therapy For Parkinsons Disease Moves Forward In Animals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... generally live in harmony with their arboreal hos...ut of space in their trees of choice, the ants can...earch, published in the November issue of the Ame...nts bore into live trees, and it reopens a centuri... plants. , Ants and certain species of plants an...
(Date:11/5/2009)...searchers at Yale University have developed synthe...ne response to HIV and HIV-infected cells, as well...ished online in the Journal of the American Chemi...oaches for these diseases. , The molecules cal...ARM-H) and "antibody-recruiting molecule targeting...
(Date:11/4/2009)...idors in the cities of Long Beach and Riverside ar...entable childhood asthma, and the true impact of a... likely been underestimated, according to research.... , The study, which appears in an online editi...imated that nine percent of all childhood asthma c...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2Kaiser Workers Statewide Campaign Starts Tuesday 55751 1Kaiser Workers Statewide Campaign Starts Tuesday 55751 2CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 1CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 2CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 3CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 4CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 5VirtualScopics to Present at the Rodman 26 Renshaw Annual Global Investment Conference 55746 1VirtualScopics to Present at the Rodman 26 Renshaw Annual Global Investment Conference 55746 2
...E, Fla. Replacing one amino acid on the surface o...ls could be the breakthrough scientists have neede...eating genetic diseases such as hemophilia, Univer...he journal Proceedings of the National Academy of ...ave developed a new version of the adeno-associate...
...bout water quality at beaches along the Great Lake... waters are safe for recreation. A new collaborati...each managers when they are faced with deciding wh...his collaborative effort will draw on the expertis...te and local agencies. , The project has been fu...
...WA The inland areas of the Pacific Northwest, whe... present growing challenges for vineyard owners an...s part of the country have not been conducive for ...y wine grapes. , To promote healthy grape product...s in the area typically employ an irrigation pract...
Other Biology News:UF researchers develop improved gene therapy agent 2UF researchers develop improved gene therapy agent 3To swim or not to swim? 2Study results: new recommendations for grape growers 2
(Date:11/6/2009)... Calbiotech, Inc. announced today ...ve Research (SBIR) Phase I contract by the U.S. Ar...rms of the agreement, Calbiotech will develop anal...Dengue virus. ,, Dengue virus is a mosquito-...military forces deployed to tropical areas of the ...
(Date:11/6/2009)...a for Arrowhead’s 2010 Personalized Medicine...ce on February 22-24, 2010 in Philadelphia, has be... highlight key issues in forming partnerships and ...s. , Minneapolis, MN (PRW...squo;s 2010 Personalized Medicine Partnerships Co...
(Date:11/5/2009)...Newswire/ -- The endangered black-footed ferrets i... rare carnivore feeds on prairie dogs. The prair...ntire population die-offs in towns occur. The U.S...d a ferret breeding program and has been releasing...ve habitat. Unfortunately, plague can sweep throu...
(Date:11/5/2009)...5 ThermoGenesis Corp. (N...roducts for processing and storing adult stem cell... fiscal 2010. ,, For the quarter ended Septembe...million, a 15 percent increase over revenues of $4...mpany said the key contributors to the growth in r...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...0 split ratio, SEATTLE, Aug. 25 Cell Therapeutic...t its Board of Directors has,authorized a 1-for-10...lit,will become effective as of August 31, 2008., ...of Annual Meeting of,Shareholders held on June 19,...ze the Board, in its discretion, to effect a rever...
...kman,Coulter, Inc. (NYSE: BEC ), a leading develo...implify, automate, and innovate complex biomedical...kman Coulter,s senior vice,president and chief fin...Healthcare Conference 2008 on Thursday, September ...wscom.com/cgi-bin/prnh/20031202/BECLOGO ), The li...
...nd business expertise, SCOTTSDALE, Ariz., Aug. 22...company that markets the Provant(R) Wound Therapy,...s to its Board of,Directors. The two new directors...harmaceuticals, and Charles "Chuck" S. Lunden, a p...://www.newscom.com/cgi-bin/prnh/20080422/LATU008 )...
Other Biology Technology:Cell Therapeutics, Inc. Announces Reverse Stock Split 2Regenesis Biomedical Announces Additions to Board of Directors 2
Rabbit Anti-Human PALLD Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Cloning and Expression Services from Molecular Biology Resources
Cat IgA ELISA Kit from Bethyl Laboratories
Ph.D.-C7C Disulfide Constrained Peptide Library Kit from New England Biolabs
Biology Products: